Barely Significant
← all excerpts

Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.

Br J Cancer · 1993 · PMC1968592 · PMID 8398704

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP = .0001actually significant
As anticipated from the SR2508 urinary excretion data, the relationship was highly significant (r = 0.626, P = .0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.